Pharmaceuticals

  • Read more: TUESDAY, 5/20 conference: “Biostatistics & FDA Regulation: The Convergence of Science & Law”
    Article

    TUESDAY, 5/20 conference: “Biostatistics & FDA Regulation: The Convergence of Science & Law”

    By The Petrie-Flom Center Biostatistics and FDA Regulation: The Convergence of Science and Law Tuesday, May 20, 2014, 8:00am – 5:00pm Wasserstein Hall, Milstein West AB, Harvard Law School, 1585 Massachusetts Ave. Symposium Presented by the Drug Information Association (DIA), the Food and Drug Law Institute (FDLI), and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law…

  • Read more: “Sanitizing” Lethal Injection
    Article

    “Sanitizing” Lethal Injection

    By Nadia N. Sawicki Oklahoma’s botched execution of Clayton Lockett has brought increased attention to an issue that I have been concerned with for years – the increased “medicalization” of legally sanctioned executions, and, in particular, the role that medical professionals and the scientific community play in this process. Until the 20th century, most executions were…

  • Read more: Call for Abstracts: Emerging Issues and New Frontiers for FDA Regulation
    Article

    Call for Abstracts: Emerging Issues and New Frontiers for FDA Regulation

    By The Petrie-Flom Center       The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to announce an upcoming collaborative academic symposium: Emerging Issues and New Frontiers for FDA Regulation Monday, October 20, 2014  Washington, DC We are currently seeking…

  • Read more: 5/20 conference: “Biostatistics & FDA Regulation: The Convergence of Science & Law”
    Article

    5/20 conference: “Biostatistics & FDA Regulation: The Convergence of Science & Law”

    By The Petrie-Flom Center Biostatistics and FDA Regulation: The Convergence of Science and Law Tuesday, May 20, 2014, 8:00am – 5:00pm Wasserstein Hall, Milstein West AB, Harvard Law School, 1585 Massachusetts Ave. Symposium Presented by the Drug Information Association (DIA), the Food and Drug Law Institute (FDLI), and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law…

  • Read more: #BELHP2014 Panel 3, Behavioral Economics and Health Care Costs
    Article

    #BELHP2014 Panel 3, Behavioral Economics and Health Care Costs

    By Nicholson Price [Ed. Note: On Friday, May 2 and Saturday, May 3, 2014, the Petrie-Flom Center hosted its 2014 annual conference: “Behavioral Economics, Law, and Health Policy.”  This is an installment in our series of live blog posts from the event; video will be available later in the summer on our website.] Our third panel, moderated by PFC Academic Fellow…

  • Read more: Summer Course for Professionals in “Pharma Law & Policy” at the University of Copenhagen
    Article

    Summer Course for Professionals in “Pharma Law & Policy” at the University of Copenhagen

    Stay abreast with recent developments and trends determining the legal and regulatory framework of the European pharmaceutical industry. What are the most significant current issues shaking and shaping the pharmaceutical industry today? The business environment and legal framework relevant to the pharmaceutical industry continues to change rapidly in the face of constant challenges posed by…

  • Read more: A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!
    Article

    A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!

    By Timo Minssen Following the approval of the European Parliament (EP) earlier last month, the Council of the European Union (the Council) adopted on 14 April 2014 a “Regulation on clinical trials on medicinal products for human use” repealing Directive 2001/20/EC.  As described in a press-release, the new law: “aims to remedy the shortcomings of…

  • Read more: How should we label these “cognitive errors” that are particularly common among MDs?
    Article

    How should we label these “cognitive errors” that are particularly common among MDs?

    By Julian Urrutia Behavioral economists are really into giving the cognitive errors they study, and the corrective policy interventions they favor, labels. “Status quo bias,” “availability bias,” “recall bias,” etc., can all be fixed through “nudges” that involve “asymmetric paternalism” and the like. Here’s an interesting “cognitive error” that I’m trying to crowd-source a label…

  • Read more: WEDNESDAY, 4/23: Reforming Brazilian Pharmaceutical Patent Policy
    Article

    WEDNESDAY, 4/23: Reforming Brazilian Pharmaceutical Patent Policy

    By The Petrie-Flom Center Reforming Brazilian Pharmaceutical Patent Policy: Lessons from the Past and the Road for the Future April 23, 12:00pm  Wasserstein Hall 1010, Harvard Law School, 1585 Massachusetts Ave. In this lecture by Pedro Paranaguá, he will discuss the report issued by the Brazilian House of Representatives in 2013 as part of an effort…

  • Read more: Announcing 2014-2016 Petrie-Flom Academic Fellow Rachel Sachs
    Article

    Announcing 2014-2016 Petrie-Flom Academic Fellow Rachel Sachs

    By The Petrie-Flom Center   We are pleased to announce that Rachel Sachs will be joining the Petrie-Flom Center later this summer as an Academic Fellow for the 2014-2016 fellowship term. In 2013, Rachel earned her J.D. magna cum laude from Harvard Law School, where she was the Articles Chair of the Harvard Law Review and a student fellow with both…